Agoracom Blog Home

Posts Tagged ‘covid19’

Loop Insights $MTRX $RACMF Completes Acquisition of Intellectual Property Assets of Locally, A Global Location Data Intelligence Company With Tier-1 Clients $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 8:24 AM on Thursday, February 18th, 2021
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png

  • Announced the completion of its previously announced acquisition of the intellectual property assets of Digital2Go Medial Networks, Inc. d/b/a Locally pursuant to an asset purchase agreement between the Company and Locally dated February 16, 2021
  • Locally is a technology company focused on providing location data intelligence and real-time consumer engagement.

VANCOUVER, British Columbia, Feb. 18, 2021 — Loop Insights Inc. (MTRX:TSXV) (RACMF:OTCQB) (“ Loop ” or the “ Company ”), a provider of contactless solutions and artificial intelligence (” AI “) to drive automated marketing, venue tracing, and contactless solutions to the brick and mortar space, is pleased to announce the completion of its previously announced acquisition (the “ Acquisition ”) of the intellectual property assets of Digital2Go Medial Networks, Inc. d/b/a Locally (“ Locally ”) pursuant to an asset purchase agreement between the Company and Locally dated February 16, 2021 (the “ APA ”). Locally is a technology company focused on providing location data intelligence and real-time consumer engagement.

Locally Acquisition Provides Loop Insights with Unparalleled Location-Based Retail Insights, Foothold in $28.95-billion Location-Based Services Industry

Rampant digitization and the increasing use of smartphones have helped grow the location-based services market to $28.95 billion in 2019, according to Allied Market Research .

As a leader in human movement intelligence data, Locally has positioned itself to enable businesses to connect their physical and digital databases through mobile location insights and marketing integration capabilities. Locally has helped well-known brands and companies such as Ford, BMW, Wyndham Resorts, Calvin Klein, Kroger, Chipotle, Napa Auto Parts, 7-11, and others access deep consumer behavioral insights across all of their marketing activation channels.

The acquisition of Locally will allow Loop Insights to incorporate Locally’s location-based data and engagement capabilities, providing Loop with new revenue opportunities with brands and retailers looking to capitalize on the increasing use of location-based services.

Loop Insights CEO, Rob Anson, stated: ”The stakes have been raised in terms of brand and consumer expectations and interactions, with consumers demanding that brands cater to their individual preferences. The unique combination of Loop’s retail transaction data capabilities and the Locally location-based engagement platform has significantly improved Loop’s capabilities across retail, hospitality, and live sports and entertainment verticals, further enabling us to amplify frictionless experiences inside and outside nearly any physical location. With over 50 billion location signals collected to date, Locally was an obvious fit to acquire and incorporate into Loop’s product offerings, and will make an immediate impact on our already robust pipeline.”

Loop’s enhanced location-based capabilities will be applicable to nearly all of its clients, creating meaningful, dynamic, and personal connections with consumers, while providing retailers with unparalleled retail insights. By connecting transaction information to the unique IDs of users, Loop is able to drive targeted marketing opportunities and real-time engagement directly to customers through its wallet pass and other engagement capabilities.

Read More: https://agoracom.com/ir/LoopInsights/forums/discussion/topics/755570-loop-insights-completes-acquisition-of-intellectual-property-assets-of-locally-a-global-location-data-intelligence-company-with-tier-1-clients/messages/2304166#message

Empower Clinics $CBDT.ca $EPWCF KAI Medical Laboratory Surpasses 1,000 COVID-19 Tests in A Day for The First Time Ever. KAI Laboratory Now Tripling in Size in Anticipation of Test Volumes by End of Q1 $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 8:47 AM on Tuesday, February 16th, 2021

Kai Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas, TX was acquired by Empower Clinics on October 6, 2020 to further advance the Company’s COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses and travel industry

  • Announced KAI Medical Laboratory (“KAI LAB”) has exceeded 1,000 COVID-19 test units in a single day for the first time.
  • As a result, Empower is announcing that KAI LAB will undergo an even larger expansion in anticipation of projected growth in COVID-19 test requirements in the U.S., Canada and international markets.

VANCOUVER BC / February 16, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(OTCQB:EPWCF)(Frankfurt:8EC) (“Empower” or the “Company“) an integrated healthcare company serving patients through medical centres, telemedicine platforms, operating a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens, is pleased to announce our KAI Medical Laboratory (“KAI LAB”) has exceeded 1,000 COVID-19 test units in a single day for the first time.

As a result, Empower is announcing that KAI LAB will undergo an even larger expansion in anticipation of projected growth in COVID-19 test requirements in the U.S., Canada and international markets.

KAI MEDICAL LABORATORY NOW EXPANDING TO TRIPLE CURRENT SIZE IN ANTICIPATION OF ANTICIPATED RAPID TEST GROWTH

KAI Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas, TX was acquired by Empower Clinics on October 6, 2020 to further advance the Company’s COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses and the travel industry. KAI experienced significant growth in its first quarter under Empower (October 2020 – December 2020), with Q4 COVID-19 test units exceeding 6,000 specimens processed, far surpassing the less than 1,000 total monthly units prior to acquisition.

As a result, on January 21st, Empower announced “Doubling KAI Medical Laboratory In Anticipation Of Test Volumes By End Of Q1.” The Company is revising this planned expansion upwards by announcing KAL LAB is now expanding by tripling its current size in anticipation of projected growth in COVID-19 test requirements.

Empower Clinics Chairman & CEO, Steven McAuley stated “Today marks a significant milestone for Empower and our shareholders. When we first acquired KAI Medical Laboratory just over four months ago, it was processing less than 1,000 specimens monthly up to that point. Today, we are announcing that KAI has surpassed 1,000 units in a day for the first time ever. This is a credit to both Yoshi Tyler, President KAI LAB and her fantastic team, supported by our business development and marketing strategies which, quite frankly, are still in an early phase. We are just getting started.”

For the purposes of facilitating the expansion, Empower has secured additional space adjacent to KAI LAB in order to separate the lab & science from logistics, admin and customer support. Materials handling staff are being added in anticipation of processing the intake of thousands of packages per day.

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics

Read More: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/755396-empower-clinics-kai-medical-laboratory-surpasses-1-000-covid-19-tests-in-a-day-for-the-first-time-ever-kai-laboratory-now-tripling-in-size/messages/2303796#message

Xphyto $XPHY.ca $XPHYF European CE-IVD Application for 25-Minute COVID-19 RT-PCR Test $NGM.ca $SONA.ca $HBP.ca $MIR.ca $IPA.ca

Posted by AGORACOM at 8:11 AM on Tuesday, February 16th, 2021
  • Expects approval as a medical device manufacturer by late February
  • European regulatory approval as a commercial in vitro diagnostic device by early March.
  • Covid-ID Lab was designed to be a rapid, accurate and robust test system with reduced operating costs and increased convenience and portability.

XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”), and its exclusive German diagnostics development partner, 3a-diagnostics GmbH (“3a”), are pleased to announce all actions and procedures required for XPhyto Therapeutics Corp.’s European regulatory application for the rapid point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system have been completed. 3a-diagnostics GmbH, Xphyto’s exclusive German diagnostics development partner, expects ISO 13485 approval as a medical device manufacturer by late February and European regulatory approval as a commercial in vitro diagnostic device (CE-IVD) for Covid-ID Lab by early March.

“We are very pleased with the team’s swift development progress,” said Hugh Rogers, CEO & Director of XPhyto. “Our goal was to create the fastest and most portable COVID-19 PCR test on the market. We are confident in our prospects for an expedited approval and look forward to commercial launch in short order”

Read More: https://agoracom.com/ir/XphytoTherapeutics/forums/discussion/topics/755390-xphyto-european-ce-ivd-application-for-25-minute-covid-19-rt-pcr-test/messages/2303789#message

Datametrex $DM.ca $DTMXF Announces Closing of Acquisition with Concierge Medical $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 8:38 AM on Thursday, February 11th, 2021
  • Closed its acquisition of 100% of Concierge Medical Consultants Inc.’s (“Concierge“) issued and outstanding securities (the “Transaction“), pursuant to terms of the share exchange agreement entered into between the Company, Concierge, and the shareholders of Concierge (the “Concierge Shareholders“) effective January 19, 2021 (the “Definitive Agreement“).
  • Concierge is an arm’s length private telehealth and medical concierge services

Toronto, Ontario–(February 11, 2021) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex) is pleased to announce that further to its press releases dated January 7, 2021 and January 22, 2021, it has closed its acquisition of 100% of Concierge Medical Consultants Inc.’s (“Concierge“) issued and outstanding securities (the “Transaction“), pursuant to terms of the share exchange agreement entered into between the Company, Concierge, and the shareholders of Concierge (the “Concierge Shareholders“) effective January 19, 2021 (the “Definitive Agreement“).

Concierge is an arm’s length private telehealth and medical concierge services company incorporated under the laws of British Columbia.

Terms of the Transaction

Pursuant to the Definitive Agreement, the Company issued 4,411,764 common shares in the capital of the Company (the “Common Shares“) to the Concierge Shareholders at a price of $0.17 per Common Share for an aggregate purchase price of $750,000.

No finder’s fee was payable in connection with the Transaction.

“Hospital ER’s and health practitioners’ clinics are making a strong push for patients who have mild symptoms to use telehealth platforms during the pandemic crisis to help alleviate the strain on emergency rooms and doctors’ offices and I believe this will continue after the pandemic crisis is over,” commented Dr. Jibran Sharif, MD, founder, and CEO of Concierge.

“Telemedicine visits are booming as doctors and patients have adopted social distancing amid the coronavirus crisis, and with the concierge services Dr. Sharif provide, we envision an end to end turnkey solution for patient healthcare,” said Marshall Gunter, CEO of Datametrex, with respect to the closing of the Transaction.

Operations of Concierge Upon Completion of the Transaction

Concierge has become a wholly-owned operating subsidiary of the Company. The Company has appointed Andrew Ryu, Marshall Gunter, and Dr. Jibran Sharif as the new board of the directors of Concierge, and Dr. Sharif is appointed as the President of Concierge following the closing of the Transaction (the “Closing“). In addition, concurrent with the Closing, the Company has entered into a employment agreement with the founder and President of Concierge, Dr. Jibran Sharif. In addition to his role as President of Concierge, Dr. Jibran Sharif will become the Chief Medical Officer of Datametrex.

Read More: https://agoracom.com/ir/DatametrexAI/forums/discussion/topics/755157-datametrex-announces-closing-of-acquisition-with-concierge-medical/messages/2303196#message

Xphyto $XPHY.ca $XPYHF to Produce Mescaline for Psychedelic Programs $NGM.ca $SONA.ca $HBP.ca $MIR.ca $IPA.ca

Posted by AGORACOM at 8:21 AM on Wednesday, February 10th, 2021
  • Focused on the synthesis of pharmaceutical grade mescaline
  • Mescaline has shown particular promise for the treatment of addiction and depression.

Xphyto Laboratories Inc., Xphyto Therapeutics Corp.’s wholly owned Alberta subsidiary, has added mescaline production to its psychedelic medicine programs. Further to the Company’s press release dated February 3, 2021, the capacity under contract with Applied Pharmaceutical Innovation will focus on the synthesis of pharmaceutical grade mescaline. Mescaline has been anecdotally recognized as a relatively safe psychedelic drug and has shown particular promise for the treatment of addiction and depression.

“In addition to our European-based psilocybin biotechnology production, the Company has now expanded its portfolio of psychedelic compounds to include mescaline. Our goal is to develop industrial scale production processes for the wholesale market and for incorporation into XPhyto’s thin film drug delivery platforms” commented Hugh Rogers, CEO & Director. “We see a significant market opportunity in the production of pharmaceutical mescaline and the standardization of dosage formulations with precise, predictable and efficient drug delivery for clinical study and therapeutic use”

Mescaline (3,4,5-trimethoxyphenethylamine) is a naturally occurring psychedelic compound found in certain cacti, including peyote, San Pedro, and Peruvian torch, and is most commonly associated with traditional Native American religious rituals and ceremonies. Mescaline is a Schedule I drug in the United States; however, it is legal in certain religious ceremonies registered by the Native American Church and its use is expanding as a supplement to various types of meditation and psychedelic therapy.

In general, psychedelic compounds have emerged as a new class of drugs with the potential to improve the treatment of mental health related medical conditions such as depression, anxiety, addiction, and trauma-related stress disorder. The Company believes that the industrial-scale production of pharmaceutical grade psilocybin and mescaline will provide a strong foundation for its psychedelic medicine programs.

Read More:https://agoracom.com/ir/XphytoTherapeutics/forums/discussion/topics/755075-xphyto-to-produce-mescaline-for-psychedelic-programs/messages/2303018#message

Empower Clinics $CBDT.ca $EPWCF Secures Medical Device Establishment Licence (MDEL) Status To Sell KAI Saliva COVID-19 PCR Test Kits In Canada $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 8:05 AM on Wednesday, February 10th, 2021
  • Announced it has secured Medical Device Establishment Licence (“MDEL”) status to sell its KAI Medical COVID-19 Saliva Test kits (“KAI Saliva”).
  • KAI Saliva is FDA EUA approved for use, has CE Mark and the saliva specimen collection device is approved by Health Canada.
  • KAI Saliva provides travellers, both foreign and domestic with a simple, fully compliant method to obtain an RT-PCR test and test result prior to arriving or coming back into to Canada or arriving to other countries that have similar executive travel orders.

VANCOUVER BC / February 10, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (8EC:Frankfurt) (EPWCF:OTCQB) (“Empower” or the “Company“) an integrated healthcare company serving patients through medical centres, telemedicine platforms, operating a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens, is pleased to announce it has secured Medical Device Establishment Licence (“MDEL”) status to sell its KAI Medical COVID-19 Saliva Test kits (“KAI Saliva”).

KAI Saliva is FDA EUA approved for use, has CE Mark and the saliva specimen collection device is approved by Health Canada. KAI Saliva provides travellers, both foreign and domestic with a simple, fully compliant method to obtain an RT-PCR test and test result prior to arriving or coming back into to Canada or arriving to other countries that have similar executive travel orders.

EMPOWER ACCELERATES ABILITY TO DISTRIBUTE AND SELL MEDICAL DEVICE PRODUCTS IN CANADA THROUGH PARTNERSHIP WITH MEDIPRO CANADA

Empower previously announced the filing of an MDEL application for the purpose of importing, distributing and selling KAI Saliva, which has experienced success upon its launch.

To accelerate the process, Empower partnered with MediPro Canada Inc. (“MediPro”) to utilize their approved MDEL status. MediPro provides healthcare products for governments, large corporations and medical facilities around the world and is led by Hon. Sheila Maureen Copps PC OC.

“We continue to see extensive demand for novel COVID-19 testing products in both private sector and public sector markets throughout North America, Mexico and Caribbean countries.” said Hon. Sheila Copps OC, Partner MediPro Canada. “Leveraging the vast network of MediPro Canada with the integrated healthcare capabilities of Empower Clinics and their novel COVID-19 testing products, makes for an ideal partnership.”

“We all have an urgent requirement for a home-based, self-administered COVID-19 saliva test kit that can help open up the economy and facilitate travel that meets the requirements of the executive travel orders.” said Steven McAuley, Chairman & CEO. “We also must utilize our resources, our reach, our capability, do everything we can to assist, be humanitarians, use our voice, strive to provide improved healthcare, and lead the path of progressive healthcare.”

Read More: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/755072-empower-clinics-secures-medical-device-establishment-licence-mdel-status-to-sell-kai-saliva-covid-19-pcr-test-kits-in-canada/messages/2303015#message

Empower $CBDT.ca $EPWCF Partners with #Rexall $MCK To Launch Integrated Healthcare Centres $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 12:26 PM on Tuesday, February 9th, 2021

Partnership Accelerates Empower’s Strategy To Execute National Healthcare Centre Expansion By Bringing Accessible and Progressive Primary Care and Para-Medical Care to Millions of Canadians

  • Announced effective February 8, 2021 a partnership with Rexall Pharmacy Group to launch the first of multiple integrated healthcare centres within Rexall pharmacies commencing in Ontario, Canada.
  • Empower will be opening primary care, plus para-medical healthcare services in each of the locations, with a target of four (4) to six (6) Medical Doctors (MD) and four (4) to six (6) paramedical practitioners per location.

VANCOUVER, BC / February 9, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company serving patients through medical centres, telemedicine platforms, operating a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens, is pleased to announce effective February 8, 2021 a partnership with Rexall Pharmacy Group to launch the first of multiple integrated healthcare centres within Rexall pharmacies commencing in Ontario, Canada.

“In our first press release of 2021 announcing the closing of our Canadian Clinics acquisition, I stated Empower had a winning business model with immediate expansion plans throughout Greater Toronto, followed by Ontario and then nationwide with at least 30 clinics in rapid succession. Empower is proud to begin delivering on that promise.” said Steven McAuley, Chairman & CEO. “To say this is the Company’s biggest announcement in its history would not be an over statement. This partnership with Rexall accelerates our nationwide healthcare expansion strategy, I look forward to bringing Six Sigma philosophies and continuous process improvements to our operations to ensure customers and our patients have access to our primary care and para-medical services for years to come. Today marks a major win for Canadian healthcare and the shareholders of Empower Clinics.”

PARTNERSHIP IDENTIFIES INITIAL LOCATIONS IN ONTARIO

Rexall and Empower have identified numerous initial locations throughout Ontario, spanning from Ottawa to London and around the GTA. The size of the locations can range from 1,500 to 4,000 square feet. As each new location is agreed upon, key terms are outlined in a letter of intent and in the lease or sub-lease agreements with the first anticipated agreements February 2021.

HEALTH CARE SERVICES TO BE DELIVERED

Empower will be opening primary care, plus para-medical healthcare services in each of the locations, with a target of four (4) to six (6) Medical Doctors (MD) and four (4) to six (6) paramedical practitioners per location.

Primary care services include:

  • Family physicians
  • Walk-in physicians
  • Tele-medicine and virtual care

Paramedical services include:

  • Chiropractic
  • Physiotherapy
  • Registered Massage Therapy
  • Chiropody
  • Acupuncturists
  • Osteopaths
  • Nutritionists

ADDITIONAL HEALTH CARE SERVICES EXPECTED TO BE ADDED

Given the anticipated expansion and penetration of Empower Clinics into the Canadian market, the Company intends to continue adding valuable specialized medical services to strengthen the quality of healthcare at each location that can include:

  • Dermatology
  • Cardiology

Read More: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/754999-empower-partners-with-rexall-r-to-launch-integrated-healthcare-centres/messages/2302856#message

VIDEO – Loop Insights $MTRX $RACMF Lands First Multi-Million $ Deal Through #TELUS $T.ca $TU Partnership $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 4:37 PM on Monday, February 8th, 2021
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png

Topics we discuss:

  • 4-Year multi-million COVID19 VenueBubble deal with Big White Ski Resort
  • Deal via Telus
  • IoT Partnership
  • UK Pilot Deals
  • New CTO from NTT DATA
  • Re-Open Vancouver with Empower Clinics

Loop Insights $MTRX $RACMF Signs Four-Year Venue Management Agreement Through #TELUS $T.ca #IoT Marketplace with Big White Ski Resort, One Of Canada’s Top 5 Ski Resorts, with Potential to Generate $7.2 – $9.6 Million in Newline Revenue For Loop and Big White Ski Resort $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 8:08 AM on Monday, February 8th, 2021
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png

Agreement a Result of Sales and Marketing Efforts Made by TELUS (T:TSX; TU: NYSE) Through its IoT Marketplace

  • Company has been selected by Big White Ski Resort to deploy its venue management platform for the purposes of providing its visitors and staff with complementary COVID-19 safety protocols through its venue management platform while also creating significant revenue opportunities for both parties.
  • Potential to generate $7.2M – $9.6M over term of agreement

VANCOUVER, British Columbia., Feb. 08, 2021 — Loop Insights Inc. (MTRX:TSXV) (RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing to the brick and mortar space, is pleased to announce the Company has been selected by Big White Ski Resort (“ Big White Ski Resort ”) to deploy its venue management platform for the purposes of providing its visitors and staff with complementary COVID-19 safety protocols through its venue management platform while also creating significant revenue opportunities for both parties.

BIG WHITE SKI RESORT SELECTS LOOP, IN PARTNERSHIP WITH TELUS, TO PROVIDE VENUE MANAGEMENT PLATFORM TO ESTABLISH INFRASTRUCTURE TO PROTECT STAFF AND GUESTS

In support of Big White Ski Resort and British Columbia’s tourism industry, Loop Insights will deploy its venue tracing solution across Big White Ski Resort and its facilities, aiding the resort to continue to ensure the safety of its staff and customers.

Having recognized the importance of accurate venue tracing protocols in the fight against COVID-19, Loop will work with Big White Ski Resort to maintain the safety of all guests and staff using the Loop venue management platform. The ultimate goal of the deployment is to provide an enhanced customer experience through guest and staff check-ins and to continue to mitigate the spread of COVID-19.

Loop’s venue tracing technology is based on a science and data-driven approach to provide businesses with complementary safety protocols. Through this latest deployment, Loop is working with Big White Ski Resort to ensure the appropriate infrastructure is in place to continue to mitigate the spread of COVID-19 through real-time alerts and automated safety updates sent via the platform.

Michael J Ballingall Senior Vice President of Big White Ski Resort stated: “After being introduced to Loop Insights’ venue management platform through our partnership with TELUS and its IoT Marketplace, Big White Ski Resort recognized its ability to provide us with the peace of mind necessary to deliver the best ski resort experience possible. Also, we are excited about the opportunities by leveraging Loop’s platform to create new revenue streams through unique marketing opportunities.”

VENUE MANAGEMENT REVENUE MODEL HAS POTENTIAL TO GENERATE $7,200,000 – $9,600,000 OVER TERM OF AGREEMENT FOR LOOP AND BIG WHITE SKI RESORT

Read More: https://agoracom.com/ir/LoopInsights/forums/discussion/topics/754885-loop-insights-signs-four-year-venue-management-agreement-through-telus-iot-marketplace-with-big-white-ski-resort-one-of-canada-s-top-5-ski-resorts/messages/2302630#message

Loop Insights $MTRX $RACMF Enters Into First Pure Ecommerce Pilot With UK’s Leading Online Electronics Retailer, #Maplin, For Real-Time Artificial Intelligence-Driven Engagement With Customers $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 8:22 AM on Thursday, February 4th, 2021
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png

Under the pilot agreement, Loop and Maplin intend to pursue joint marketing and revenue sharing opportunities through SaaS and ARPU (Average Revenue Per User) models

  • Announced the launch of a Pilot agreement with Maplin Electronics, the UK’s leading online electronics retailer, to implement Loop’s real-time artificial intelligence analytics platform.
  • Loop Insights CEO, Rob Anson, stated, “This opportunity with Maplin represents our first enterprise eCommerce retailer, providing Loop with a tremendous opportunity to demonstrate the power of our real-time, artificial intelligence-driven engagement to online customers….”

VANCOUVER, British Columbia, Feb. 04, 2021 — Loop Insights Inc. (MTRX:TSXV (RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing to the brick and mortar space, is pleased to announce the launch of a Pilot agreement with Maplin Electronics, the UK’s leading online electronics retailer, to implement Loop’s real-time artificial intelligence analytics platform.

Loop Insights CEO, Rob Anson, stated, “This opportunity with Maplin represents our first enterprise eCommerce retailer, providing Loop with a tremendous opportunity to demonstrate the power of our real-time, artificial intelligence-driven engagement to online customers. Loop will deliver operational efficiencies for Maplin by providing real-time intelligence focused on supply chain and demand analysis, as well as inventory and fulfillment analytics, enabling us to showcase our AI forecasting tools. I have every reason to believe the pilot will be a great success for Maplin and open up the door to further lucrative global enterprise eCommerce opportunities.”

Agreement with Maplin Represents Loop’s Continued Expansion Into UK’s Retail Industry, Including Brick and Mortar and Now Ecommerce

Under the terms of the agreement, Loop will deploy its Insights platform consisting of the Company’s web-based portal, analytics dashboard, and AI-driven retail insights. Maplin will also provide Loop with access to web traffic data from its eCommerce platform, allowing the Company to create a unified picture of Maplin’s retail business in the digital world, thus creating new opportunities for increased revenues, consumer engagement, and data monetization.

Upon successful completion of the Pilot, it is the intention of both parties to implement Loop’s artificial intelligence-driven analytics platform for both Maplin and all of its suppliers including major electronics brands such as Sony, Panasonic, and Samsung.

Maplin Managing Director, Ollie Marshall, stated, “The signing of this agreement with Loop Insights is the first step towards enhancing our retail capabilities as Maplin looks to optimize its eCommerce operations. As a company that is 100% online, we are dedicated to remaining true to our consumer-focused brand, offering quality electronic products for consumers across Europe. Loop’s AI-driven retail insights add a new dimension to Maplin’s operations that will greatly optimize our operations and improve our overall customer experience.”

Insights Revenue Model Provides Potential For Recurring Annual Revenue Streams, Including Annual SaaS Licenses and ARPU (Average Revenue Per User) Fees

In previous press releases announcing new and completed successful pilots, Loop has provided shareholders with details pertaining to its pricing models for greater transparency. Each of those models pertained to physical chain locations with numerous tills per location.

The nature of this eCommerce Pilot Agreement does not include tills. As such, Loop expects to generate revenue through ongoing SaaS and ARPU (Average revenue per user) fees in addition to data analysis that will provide both Maplin and suppliers with an improved understanding of consumer trends. In addition, when the Company’s automated marketing “Engage” service and wallet pass loyalty applications are layered in, these numbers quickly multiply by 5-10x and provide the company with an even more significant potential revenue stream.

Finally, both Loop and Maplin intend to pursue additional monetization opportunities on a revenue-sharing basis using Loop’s brand segmentation capabilities. Maplin and Loop expect to also generate revenues through combined data sharing opportunities with Maplin suppliers and brands seeking retail insights data that can be leveraged for targeted omnichannel advertising. Under the Maplin model, these targeted marketing opportunities are expected to drive sales of niche and seasonal goods based on the optimization of trends and consumer data.

Read More: https://agoracom.com/ir/LoopInsights/forums/discussion/topics/754638-loop-insights-enters-into-first-pure-ecommerce-pilot-with-uk-s-leading-online-electronics-retailer-maplin-for-real-time-artificial-intelligence/messages/2301974#message